Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

US Patent 11542261 · Granted Jan 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62025
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2024
Methods and compositions for treatment of myelodysplastic syndromes and/or acute2023
ALK2 inhibitors and methods for inhibiting BMP signaling2023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Methods and compositions for treatment of myelodysplastic syndromes and/or acute2023
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors2022
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors2022
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors2022
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors2022
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors2022